Home / Inspections / 1192251

FDA Inspection 1192251 — Ohio Reproductive Medicine, Inc.

Ohio Reproductive Medicine, Inc. — FEI 3004563989

The FDA completed an inspection of Ohio Reproductive Medicine, Inc. on December 1, 2022 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 1, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbus, OH (United States)

Facility

Other inspections at this facility

  • 1089668 (NAI Wed May 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998459 (NAI Fri Jan 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 907450 (NAI Fri Dec 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805075 (NAI Fri Oct 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources